• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
2,067.80 -66 (-3.11%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    2,053.70

  • Today’s High

    2,133.00

  • Open

    2,133.00

  • Perv Close

    2,134.10

  • 52W Low

    1,275.50

  • 52W High

    2,284.80

Key Indicators

  • P/E(TTM)

    33.44

  • Mar.Cap (₹Cr.)

    58,353.48

  • Div & Yield %

    0.12

  • Book Value(₹)

    868.32

  • Debt-Equity Ratio

    -3.11

  • AGM Date

    01-Aug-2025

  • EPS

    61.81

  • P/E Ratio

    33.44

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    58,353.48

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    868.30

  • Sales( ₹ in Cr.)

    9,010.54

  • NP (in Cr.)

    1,744.30

  • NP Var(%)

    22.0

  • Div%

    250.0

  • CPS (₹)

    69.60

  • EPS (₹)

    61.80

  • Traded Value (₹ in Lakhs)

    58,329.50

  • 52 Week High

    2,284.80

  • 52 Week Low

    1,275.50

  • Price BSE

    2067.0

  • Price NSE

    2,068.00

  • Market Capital( in Cr.)

    58,329.50

  • P/C Ratio

    29.70

  • P/E Ratio

    33.40

  • Price Vs.BV

    61.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Other Income 6,238.36 985.94 1,044.96 470.13 625.34 954.61
Stock Adjustments 103.07 31.37 16.13 -5.24 -48.77 -471.81
Total Income 14,232.55 9,237.97 9,202.67 8,032.82 7,289.20 6,787.67
EXPENDITURE :            
Raw Materials 3,313.19 3,427.07 3,474.66 2,944.53 2,617.22 1,887.15
Power and Fuel Cost 104.92 95.09 91.34 80.49 90.76 82.99
Employee Cost 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Other Manufacturing Expenses 375.32 304.66 297.44 267.26 230.03 218.75
Selling and Administration Expenses 1,199.17 1,246.10 1,062.89 914.37 977.77 992.83
Miscellaneous Expenses 325.15 855.71 349.97 358.30 371.53 353.89
Employee Benefit Expenses 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,752.52 7,275.13 6,469.50 5,672.35 5,359.63 4,505.58
Operating Profit 7,480.02 1,962.84 2,733.18 2,360.47 1,929.57 2,282.08
Interest 277.11 206.82 236.04 265.90 256.39 223.81
Gross Profit 7,202.91 1,756.02 2,497.14 2,094.57 1,673.18 2,058.27
Depreciation 202.16 184.15 159.70 150.82 138.54 106.28
Profit Before Tax 7,000.75 1,571.87 2,337.44 1,943.75 1,534.64 1,951.99
Current Tax 1,049.99 386.93 411.08 343.62 269.24 383.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 783.46 -23.83 -71.42 -49.31 -89.14 -53.61
Reported Net Profit 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,622.11
Extraordinary Items 3,742.26 -369.56 354.02 59.87 14.43 277.16
Adjusted Net Profit 1,425.03 1,578.33 1,643.77 1,589.58 1,340.12 1,344.95
Adjustment below Net Profit -4.76 0.63 1.61 2.48 -5.42 -3.54
P & L Balance brought forward 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38 8,508.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 77.22 70.54 57.30 70.54 68.03 68.03
P & L Balance carried down 21,088.13 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 250.00 250.00 250.00 250.00 200.00
Dividend Per Share(Rs) 2.50 2.50 2.50 2.50 2.50 2.00
Earnings Per Share-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Earnings Per Share(Adj)-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Book Value 814.01 633.57 593.21 524.84 468.73 423.22
Book Value(Adj)-Unit Curr 814.01 633.57 593.21 524.84 468.73 423.22

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,391,001 1.20 3,391,001 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.44 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,632,937 46.65 131,632,937 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,631 0.04 107,631 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,240 0.00 1,240 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 58,203,030 20.62 58,203,030 324
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,293,429 0.46 1,293,429 15
Mutual Funds / UTI 43,884,095 15.55 43,884,095 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,592,876 1.63 4,592,876 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 108,082,301 38.30 108,082,301 396
2] Non Institution
Bodies Corporate 6,456,262 2.29 6,456,262 1,008
Clearing Members 5,507 0.00 5,507 7
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,155,276 0.76 2,151,276 4,740
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 537,473 0.19 537,473 3,317
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,040,796 3.91 10,440,796 15
Individuals holding nominal share capital up to Rs. 1 lakh 21,938,631 7.77 21,711,297 180,705
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 60,956 0.02 60,956 13
Others 290,670 0.10 290,670 3
Sub Total 42,485,571 15.06 41,654,237 189,808
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,200,809 100.00 281,369,475 190,210

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 2,066.95 9,059.14 7,891.12 36.22 9.75
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10